<b>Background/Objectives:</b> Although O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is a key predictive biomarker in glioblastoma, its association with clinical and lifestyle characteristics remains poorly understood. This evidence concerns the gene MGMT and glioblastoma.